JNJ240927P187500
- 21.20
- 0.000.00%
Johnson & Johnson Newsroom
UCB Gets Expanded FDA Approval for Psoriasis Drug Bimzelx
10 Health Care Stocks With Whale Alerts In Today's Session
Talcum powder cancer litigants: Johnson & Johnson subsidiary's third bankruptcy application should be rejected.
Johnson & Johnson (JNJ.US) subsidiary Red River Talc LLC made its third attempt last week to file for bankruptcy to resolve an approximately $8 billion settlement accepted by 83% of baby powder litigants. However, lawyers who have long fought against Johnson & Johnson for compensation argued on Monday that the bankruptcy filing should be rejected because it violates the precedent of the US Supreme Court and distorts the purpose of the US bankruptcy system. According to a recent decision by the US Supreme Court earlier this year, Johnson & Johnson cannot force women with ovarian cancer to join the proposed $8 billion settlement agreement. In June of this year, a US judge rejected the proposal by a 5-4 vote.
J&J Needs to End Talc Lawsuits. The Third Time Could Be the Charm. -- Barrons.com
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Johnson & Johnson Marks 50 Years In Singapore With Range Of Events
Novartis' Pluvicto Expected to Dominate Prostate Cancer Radiopharmaceutical Market
Is Johnson & Johnson (JNJ) the Best Future Stock For The Long-Term?
Express News | Johnson & Johnson subsidiary applies for bankruptcy protection due to talcum powder-caused cancer issues.
Sanofi Sarclisa Combo Gains Approval as First-line Multiple Myeloma Treatment
Johnson & Johnson Boosts Talc Settlement Payment to $8 Billion in Unit's Bankruptcy Case
Johnson & Johnson Files Third Bankruptcy Case Seeking to End Talc Lawsuits -- WSJ
Express News | Johnson & Johnson Shares Lose Ground Very Slightly, Last Down 0.6%
Express News | johnson & johnson (JNJ): In the baby powder cancer case, 83% of the plaintiffs support the company's proposed bankruptcy reorganization plan. The settlement costs have been further increased to over 8 billion US dollars.
Express News | J&J: Contemplated Settlement Represents Present Value of About $8 Bln to Be Paid Over 25 Years, Totaling About $10 Billion Nominal
Express News | J&J: Company Reiterates That None of Talc-Related Claims Against It Have Merit
Express News | J&J: Plan Would Resolve 99.75% of All Pending Talc Lawsuits Against Johnson & Johnson and Its Affiliates in the United States
Express News | J&J -Approximately 83% of Current Claimants and the Future Claims Representative Support the Proposed Bankruptcy Plan
Express News | J&J - Red River Increased Its Settlement Commitment by $1.75 Billion to Approximately $8 Billion